Function of Blood Plasma
Plasma, the largest component of blood, accounts for 55% of total blood composition. It consists of several components—water, electrolytes, albumin and immunoglobulins, among others.
Blood plasma is used to treat patients with immunoglobulin deficiency. Exploring the potential of blood plasma in the large-scale treatment of immuno-compromised patients has become essential with the emerging incidences of both primary and secondary immunodeficiencies.
An increase in the cases of bleeding disorders such as hemophilia A, hemophilia B and von Willebrand disease has resulted in a better understanding of blood plasma and its potential in the treatment of these diseases.
That’s why studying blood plasma products is so crucial—to deepen the understanding of blood plasma and the potential of using blood plasma therapies in chronic disease management.
Blood Plasma Market Trends
Immunodeficiency, the major factor responsible for severe infections in immuno-compromised patients, is a significant concern throughout the world and is expected to drive growth in the global blood plasma products market.
New product launches, improvements in existing technologies and increased R&D activity are increasing demand for blood plasma products in the global market.
Factors that may restrain the market’s growth include the high cost of therapies and the threat of blood-borne disease transmission. Ensuring safety and efficacy during blood donations and transfusions will aid in overcoming these threats.
Blood Plasma Market Projections
For additional intel into the global blood plasma products market, download a free overview of our report, Global Markets for Blood Plasma Products.